Mike Doustdar, new CEO of Ozempic maker, Novo Nordisk discusses his strategy for the future of the company.
Monday - Friday, 08:00 - 11:00 CET | 14:00 - 17:00 HK/SG
Get this delivered to your inbox, and more info about our products and services.
Novo Nordisk CEO Mike Doustdar discusses the pharma giant's Q4 reporting, uptake of obesity drugs and how he plans to navigate…
Charlotte Reed speaks with Mike Doustdar, CEO of Novo Nordisk, after the Danish comapny hiked its 2026 full-year guidance on the…
Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before.
Jorgensen, who joined in 2017, has had the shortest tenure of all. Danish couple August and Marie Krogh founded Nordsik…
The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its…
Novo Nordisk CEO Mike Doustdar told Jim Cramer about developments in obesity treatment.
